Lenox Wealth Advisors’s AngioDynamics ANGO Stock Holding History
Bought
Maintained
Sold
Other funds holding ANGO
SFM
Lenox Wealth Advisors's ANGO Position: Q2 2020 in Review
Lenox Wealth Advisors sold out of AngioDynamics (ANGO) in Q2 2020, closing a stake of 90 shares — an estimated $1K sold.
Lenox Wealth Advisors first reported a position in ANGO in Q3 2019 and held it in 3 quarters. The position peaked at $2K in Q3 2019. 146 funds tracked by Wall St. Rank hold ANGO as of Q2 2020.
- Lenox Wealth Advisors reported no remaining AngioDynamics position as of Q2 2020 after selling out during the quarter.
- Lenox Wealth Advisors sold 90 AngioDynamics shares in Q2 2020, an estimated $1K.
- Lenox Wealth Advisors first reported a position in AngioDynamics in Q3 2019 and held it in 3 quarters.
- Lenox Wealth Advisors's AngioDynamics position peaked at $2K in Q3 2019.
- 146 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2020.
Based on Lenox Wealth Advisors's 13F filing for Q2 2020, filed 14 Jul 2020.